Keyphrases
Advanced Cirrhosis
22%
Advanced Fibrosis
44%
Aflatoxin
100%
Aflatoxin Exposure
11%
Breast Cancer Susceptibility Gene 1 (BRCA1)
11%
Cell Cycle Control
11%
Chromosomal Replication
11%
Cirrhosis
22%
Dietary Exposure
11%
DNA Damage Response
11%
Droplet Digital PCR (ddPCR)
11%
E2F Transcription Factor 1 (E2F1)
22%
E2F4
11%
Etiology
11%
Family Members
11%
Hepatocellular Carcinoma
100%
Hepatocellular Carcinoma Patients
11%
High Incidence
11%
Hispanic
100%
In(III)
11%
Overall Survival
11%
Plasma Cell-free DNA
22%
Promising Biomarkers
11%
Risk Assessment
11%
Risk Biomarkers
11%
Somatic mutation
11%
South Texas
100%
Tumor
11%
Upstream Regulator
11%
Worse Prognosis
11%
Young Age
11%
Medicine and Dentistry
Aflatoxin
100%
Biological Marker
14%
BRCA1
14%
Cell Cycle Regulation
14%
Cell-Free DNA
28%
Chromosome Replication
14%
Dietary Exposure
14%
DNA Damage Response
14%
Droplet Digital Polymerase Chain Reaction
14%
Fibrosis
57%
Hepatocellular Carcinoma
100%
Liver Cirrhosis
57%
Malignant Neoplasm
14%
Overall Survival
14%
Prevalence
100%
Restriction Fragment Length Polymorphism
14%
Somatic Mutation
14%
Tumor
14%
Pharmacology, Toxicology and Pharmaceutical Science
Aflatoxin
100%
Biological Marker
14%
Dietary Exposure
14%
Fibrosis
57%
Liver Cell Carcinoma
100%
Liver Cirrhosis
57%
Malignant Neoplasm
14%
Overall Survival
14%
Prevalence
100%